A company insider recently sold 26,574 shares of Acadia Pharmaceuticals Inc [ACAD]. Should You Sale?
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Acadia Pharmaceuticals Inc shares valued at $474,877 were sold by DAVIS STEPHEN on Apr 08 ’24. At $17.87 per share, DAVIS STEPHEN sold 26,574 shares. The insider’s holdings dropped to 144,267 […]
ACAD (Acadia Pharmaceuticals Inc) may reap gains as insiders became active recently
Acadia Pharmaceuticals Inc’s recently made public that its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.47 million on Apr 08 ’24. In the deal valued at $17.87 per share,26,574 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 144,267 shares worth roughly $2.47 million. Then, Schneyer Mark C. sold 2,716 […]
Negative sentiment towards ACAD reflected in surge in short interest
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Acadia Pharmaceuticals Inc shares valued at $474,877 were sold by DAVIS STEPHEN on Apr 08 ’24. At $17.87 per share, DAVIS STEPHEN sold 26,574 shares. The insider’s holdings dropped to 144,267 shares worth approximately $2.56 million following […]
Acadia Pharmaceuticals Inc [ACAD] CEO makes an insider sale of 17,714 shares worth $0.32 million.
In a filing, Acadia Pharmaceuticals Inc revealed its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.32 million on Mar 27 ’24. In the deal valued at $17.90 per share,17,714 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 118,842 shares worth roughly $2.14 million. Then, Schneyer Mark C. sold 5,434 […]
A company insider recently sold 17,714 shares of Acadia Pharmaceuticals Inc [ACAD]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Acadia Pharmaceuticals Inc shares valued at $317,081 were sold by DAVIS STEPHEN on Mar 27 ’24. At $17.90 per share, DAVIS STEPHEN sold 17,714 shares. The insider’s holdings dropped to 118,842 shares worth approximately […]
Potential Price Increase for Acadia Pharmaceuticals Inc (ACAD) After Recent Insider Activity
Acadia Pharmaceuticals Inc’s recent filing unveils that its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.32 million on Mar 27 ’24. In the deal valued at $17.90 per share,17,714 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 118,842 shares worth roughly $2.2 million. Then, Schneyer Mark C. sold 5,434 […]
Potential Price Increase for Acadia Pharmaceuticals Inc (ACAD) After Recent Insider Activity
Acadia Pharmaceuticals Inc’s recent filing unveils that its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.32 million on Mar 27 ’24. In the deal valued at $17.90 per share,17,714 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 118,842 shares worth roughly $2.2 million. Then, Schneyer Mark C. sold 5,434 […]
An Analysis of Acadia Pharmaceuticals Inc (ACAD)’s Potential Price Growth
In a filing, Acadia Pharmaceuticals Inc revealed its CEO DAVIS STEPHEN unloaded Company’s shares for reported $0.14 million on Feb 26 ’24. In the deal valued at $24.67 per share,5,577 shares were sold. As a result of this transaction, DAVIS STEPHEN now holds 101,890 shares worth roughly $1.82 million. Then, Schneyer Mark C. sold 772 […]
Rise in ACAD’s short interest indicates Bearish sentiment
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Acadia Pharmaceuticals Inc shares valued at $137,585 were sold by DAVIS STEPHEN on Feb 26 ’24. At $24.67 per share, DAVIS STEPHEN sold 5,577 shares. The insider’s holdings dropped to 101,890 shares worth approximately […]
